| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 6.41e-11 | 4 | 58 | 4 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 6.41e-11 | 4 | 58 | 4 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 3.20e-10 | 5 | 58 | 4 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 2.23e-09 | 7 | 58 | 4 | GO:0050294 | |
| GeneOntologyMolecularFunction | sulfate binding | 7.99e-09 | 9 | 58 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 1.33e-08 | 10 | 58 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 4.49e-08 | 13 | 58 | 4 | GO:0050656 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.96e-05 | 55 | 58 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 6.34e-05 | 74 | 58 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | nuclear import signal receptor activity | 1.52e-03 | 20 | 58 | 2 | GO:0061608 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 2.81e-10 | 5 | 58 | 4 | GO:0018960 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | TSKU SULT1A2 SULT1A4 SULT1A1 SULT1A3 SDR42E2 ARMC5 CH25H DGKQ DKKL1 | 8.62e-08 | 376 | 58 | 10 | GO:0008202 |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 1.30e-07 | 17 | 58 | 4 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 1.30e-07 | 17 | 58 | 4 | GO:0034035 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 1.30e-07 | 17 | 58 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.67e-07 | 18 | 58 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 4.79e-07 | 23 | 58 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 9.41e-07 | 27 | 58 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 5.92e-06 | 13 | 58 | 3 | GO:0009812 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 9.17e-06 | 47 | 58 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.20e-05 | 106 | 58 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.38e-05 | 52 | 58 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 4.92e-05 | 142 | 58 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 4.92e-05 | 142 | 58 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 4.92e-05 | 142 | 58 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 5.30e-05 | 73 | 58 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 5.59e-05 | 74 | 58 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 5.59e-05 | 74 | 58 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | TSKU SULT1A2 SULT1A4 SULT1A1 SULT1A3 CH25H DGKQ DKKL1 ALOX15B | 6.98e-05 | 641 | 58 | 9 | GO:1901615 |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 1.51e-04 | 412 | 58 | 7 | GO:0006066 | |
| GeneOntologyBiologicalProcess | organophosphate metabolic process | SULT1A2 SULT1A4 PPT2 SULT1A1 SULT1A3 MTOR PIK3CB DGKQ AK9 NNT ALOX15B | 2.95e-04 | 1142 | 58 | 11 | GO:0019637 |
| GeneOntologyBiologicalProcess | steroid biosynthetic process | 3.02e-04 | 209 | 58 | 5 | GO:0006694 | |
| GeneOntologyBiologicalProcess | dopamine catabolic process | 3.45e-04 | 10 | 58 | 2 | GO:0042420 | |
| GeneOntologyBiologicalProcess | biogenic amine metabolic process | 3.74e-04 | 121 | 58 | 4 | GO:0006576 | |
| GeneOntologyBiologicalProcess | lipid biosynthetic process | 4.13e-04 | 813 | 58 | 9 | GO:0008610 | |
| GeneOntologyBiologicalProcess | catecholamine catabolic process | 4.21e-04 | 11 | 58 | 2 | GO:0042424 | |
| GeneOntologyBiologicalProcess | catechol-containing compound catabolic process | 4.21e-04 | 11 | 58 | 2 | GO:0019614 | |
| GeneOntologyBiologicalProcess | wound healing | 4.48e-04 | 493 | 58 | 7 | GO:0042060 | |
| GeneOntologyBiologicalProcess | sulfur compound metabolic process | 5.49e-04 | 365 | 58 | 6 | GO:0006790 | |
| GeneOntologyBiologicalProcess | regulation of steroid metabolic process | 5.66e-04 | 135 | 58 | 4 | GO:0019218 | |
| GeneOntologyBiologicalProcess | nucleotide metabolic process | 6.22e-04 | 684 | 58 | 8 | GO:0009117 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate metabolic process | 6.65e-04 | 691 | 58 | 8 | GO:0006753 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 6.67e-04 | 141 | 58 | 4 | GO:0006805 | |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 6.85e-04 | 142 | 58 | 4 | GO:0018958 | |
| GeneOntologyBiologicalProcess | thrombin-activated receptor signaling pathway | 6.92e-04 | 14 | 58 | 2 | GO:0070493 | |
| GeneOntologyBiologicalProcess | phenol-containing compound catabolic process | 6.92e-04 | 14 | 58 | 2 | GO:0019336 | |
| GeneOntologyBiologicalProcess | amine metabolic process | 7.99e-04 | 148 | 58 | 4 | GO:0009308 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 1.09e-04 | 6 | 57 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 1.09e-04 | 6 | 57 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 2.02e-04 | 8 | 57 | 2 | GO:0002139 | |
| GeneOntologyCellularComponent | mitotic spindle midzone | 8.55e-04 | 16 | 57 | 2 | GO:1990023 | |
| MousePheno | enlarged gallbladder | 3.02e-06 | 28 | 51 | 4 | MP:0009342 | |
| MousePheno | abnormal gallbladder size | 5.24e-06 | 32 | 51 | 4 | MP:0020134 | |
| MousePheno | abnormal gallbladder morphology | 6.59e-05 | 60 | 51 | 4 | MP:0005084 | |
| Domain | ARM-type_fold | ARFGEF3 URB1 MTOR PIK3CB NEK10 TNPO2 ARMC5 IPO4 ECPAS NCAPG2 | 5.77e-08 | 339 | 56 | 10 | IPR016024 |
| Domain | HEAT | 8.20e-07 | 58 | 56 | 5 | IPR000357 | |
| Domain | HEAT_REPEAT | 2.11e-06 | 70 | 56 | 5 | PS50077 | |
| Domain | Sulfotransferase_dom | 3.97e-06 | 36 | 56 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 3.97e-06 | 36 | 56 | 4 | PF00685 | |
| Domain | - | 4.31e-06 | 222 | 56 | 7 | 1.25.10.10 | |
| Domain | HEAT | 1.28e-05 | 48 | 56 | 4 | PF02985 | |
| Domain | ARM-like | 1.55e-05 | 270 | 56 | 7 | IPR011989 | |
| Domain | IMPORTIN_B_NT | 7.85e-04 | 14 | 56 | 2 | PS50166 | |
| Domain | IBN_N | 9.04e-04 | 15 | 56 | 2 | PF03810 | |
| Domain | PI3/4_kinase_CS | 9.04e-04 | 15 | 56 | 2 | IPR018936 | |
| Domain | - | 1.03e-03 | 16 | 56 | 2 | 1.10.1070.11 | |
| Domain | IBN_N | 1.03e-03 | 16 | 56 | 2 | SM00913 | |
| Domain | PI3Kc | 1.03e-03 | 16 | 56 | 2 | SM00146 | |
| Domain | Importin-beta_N | 1.17e-03 | 17 | 56 | 2 | IPR001494 | |
| Domain | PI3/4_kinase_cat_dom | 1.31e-03 | 18 | 56 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 1.31e-03 | 18 | 56 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 1.31e-03 | 18 | 56 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 1.31e-03 | 18 | 56 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 1.31e-03 | 18 | 56 | 2 | PS00916 | |
| Domain | RA | 5.21e-03 | 36 | 56 | 2 | PF00788 | |
| Domain | RA | 5.50e-03 | 37 | 56 | 2 | PS50200 | |
| Domain | SOCS_box | 5.79e-03 | 38 | 56 | 2 | PF07525 | |
| Domain | SOCS_box | 6.09e-03 | 39 | 56 | 2 | SM00969 | |
| Domain | SOCS | 6.09e-03 | 39 | 56 | 2 | PS50225 | |
| Domain | SOCS_box | 6.09e-03 | 39 | 56 | 2 | IPR001496 | |
| Domain | ARM_REPEAT | 6.40e-03 | 40 | 56 | 2 | PS50176 | |
| Domain | RA_dom | 6.40e-03 | 40 | 56 | 2 | IPR000159 | |
| Domain | Armadillo | 8.75e-03 | 47 | 56 | 2 | IPR000225 | |
| Domain | PH_dom-like | 8.87e-03 | 426 | 56 | 5 | IPR011993 | |
| Domain | PH | 9.62e-03 | 278 | 56 | 4 | SM00233 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 3.07e-10 | 5 | 41 | 4 | M47807 | |
| Pathway | KEGG_SULFUR_METABOLISM | 4.32e-08 | 13 | 41 | 4 | M18256 | |
| Pathway | WP_ESTROGEN_METABOLISM | 4.34e-07 | 22 | 41 | 4 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.24e-07 | 23 | 41 | 4 | MM14597 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 6.27e-07 | 24 | 41 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 4.71e-06 | 39 | 41 | 4 | MM15695 | |
| Pathway | WP_RETINOL_METABOLISM | 7.68e-06 | 44 | 41 | 4 | MM15851 | |
| Pathway | KEGG_MEDICUS_REFERENCE_FLT3LG_FLT3_RAS_PI3K_SIGNALING_PATHWAY | 1.01e-05 | 15 | 41 | 3 | M47475 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.38e-05 | 107 | 41 | 5 | MM14595 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 1.51e-05 | 17 | 41 | 3 | M39483 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | 1.51e-05 | 109 | 41 | 5 | M18788 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 7.92e-05 | 29 | 41 | 3 | M45015 | |
| Pathway | WP_ARYLAMINE_METABOLISM | 1.23e-04 | 6 | 41 | 2 | M39437 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_PDGFR_TO_PI3K_SIGNALING_PATHWAY | 2.29e-04 | 8 | 41 | 2 | M47399 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_EGFR_TO_PI3K_SIGNALING_PATHWAY | 2.29e-04 | 8 | 41 | 2 | M47394 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_RET_TO_PI3K_SIGNALING_PATHWAY | 2.29e-04 | 8 | 41 | 2 | M47715 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 2.93e-04 | 9 | 41 | 2 | M47397 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_MET_TO_PI3K_SIGNALING_PATHWAY | 2.93e-04 | 9 | 41 | 2 | M47490 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PI3K_SIGNALING_PATHWAY | 2.93e-04 | 9 | 41 | 2 | M47481 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 3.39e-04 | 47 | 41 | 3 | M19708 | |
| Pathway | KEGG_MEDICUS_VARIANT_EGFR_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 3.66e-04 | 10 | 41 | 2 | M47400 | |
| Pathway | REACTOME_DRUG_ADME | 3.84e-04 | 119 | 41 | 4 | MM15692 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.11e-04 | 219 | 41 | 5 | MM14838 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 4.19e-04 | 220 | 41 | 5 | M10320 | |
| Pathway | KEGG_MEDICUS_REFERENCE_KITLG_KIT_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47403 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF2_IGF1R_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47484 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47499 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_NNK_NNN_TO_PI3K_SIGNALING_PATHWAY_N01339 | 4.46e-04 | 11 | 41 | 2 | M47791 | |
| Pathway | KEGG_MEDICUS_REFERENCE_AREG_EGFR_PI3K_SIGNALING_PATHWAY | 4.46e-04 | 11 | 41 | 2 | M47501 | |
| Pathway | KEGG_MEDICUS_VARIANT_ERBB2_OVEREXPRESSION_TO_PI3K_SIGNALING_PATHWAY | 5.35e-04 | 12 | 41 | 2 | M47393 | |
| Pathway | WP_RESOLVIN_E1_AND_RESOLVIN_D1_SIGNALING_DECREASE_INFLAMMATION | 5.35e-04 | 12 | 41 | 2 | M45559 | |
| Pathway | KEGG_ACUTE_MYELOID_LEUKEMIA | 5.99e-04 | 57 | 41 | 3 | M19888 | |
| Pathway | KEGG_MEDICUS_REFERENCE_PDGF_PDGFR_PI3K_SIGNALING_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M47398 | |
| Pathway | KEGG_MEDICUS_REFERENCE_IGF_IGF1R_PI3K_SIGNALING_PATHWAY | 6.31e-04 | 13 | 41 | 2 | M47603 | |
| Pathway | KEGG_MEDICUS_VARIANT_DUPLICATION_OR_MUTATION_ACTIVATED_FLT3_TO_RAS_PI3K_SIGNALING_PATHWAY | 7.35e-04 | 14 | 41 | 2 | M47390 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_RAS_PI3K_SIGNALING_PATHWAY | 8.46e-04 | 15 | 41 | 2 | M47389 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RELN_VLDLR_PI3K_SIGNALING_PATHWAY | 8.46e-04 | 15 | 41 | 2 | M47663 | |
| Pathway | KEGG_GLIOMA | 8.80e-04 | 65 | 41 | 3 | M1835 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | 9.89e-04 | 153 | 41 | 4 | MM15844 | |
| Pathway | WP_ACUTE_MYELOID_LEUKEMIA | 1.00e-03 | 68 | 41 | 3 | M48322 | |
| Pathway | WP_EGFR_TYROSINE_KINASE_INHIBITOR_RESISTANCE | 1.85e-03 | 84 | 41 | 3 | M39839 | |
| Pathway | KEGG_ERBB_SIGNALING_PATHWAY | 2.04e-03 | 87 | 41 | 3 | M12467 | |
| Pathway | WP_PANCREATIC_ADENOCARCINOMA_PATHWAY | 2.18e-03 | 89 | 41 | 3 | M39732 | |
| Pathway | KEGG_PROSTATE_CANCER | 2.18e-03 | 89 | 41 | 3 | M13191 | |
| Pathway | WP_4HYDROXYTAMOXIFEN_DEXAMETHASONE_AND_RETINOIC_ACIDS_REGULATION_OF_P27_EXPRESSION | 2.37e-03 | 25 | 41 | 2 | M39574 | |
| Pathway | WP_ERBB_SIGNALING | 2.40e-03 | 92 | 41 | 3 | M39715 | |
| Pathway | REACTOME_REGULATION_OF_PTEN_GENE_TRANSCRIPTION | 2.77e-03 | 27 | 41 | 2 | MM15537 | |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 24318996 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 8424956 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 33414449 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 8943792 | ||
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 8288252 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 6.96e-12 | 4 | 58 | 4 | 12390022 | |
| Pubmed | 6.96e-12 | 4 | 58 | 4 | 25370010 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 11389699 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 29908303 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 24802129 | ||
| Pubmed | 3.48e-11 | 5 | 58 | 4 | 25053625 | ||
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 12438748 | ||
| Pubmed | 2.43e-10 | 7 | 58 | 4 | 9370299 | ||
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 4.85e-10 | 8 | 58 | 4 | 10594240 | |
| Pubmed | 8.72e-10 | 9 | 58 | 4 | 9166597 | ||
| Pubmed | 8.72e-10 | 9 | 58 | 4 | 8887328 | ||
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 8.72e-10 | 9 | 58 | 4 | 23207770 | |
| Pubmed | 8.72e-10 | 9 | 58 | 4 | 8468045 | ||
| Pubmed | 8.72e-10 | 9 | 58 | 4 | 19548878 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 8.72e-10 | 9 | 58 | 4 | 9060415 | |
| Pubmed | 8.72e-10 | 9 | 58 | 4 | 9177785 | ||
| Pubmed | 1.45e-09 | 10 | 58 | 4 | 7601475 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 2.28e-09 | 11 | 58 | 4 | 7613026 | |
| Pubmed | 2.28e-09 | 11 | 58 | 4 | 11154739 | ||
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 2.28e-09 | 11 | 58 | 4 | 8954725 | |
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 2.28e-09 | 11 | 58 | 4 | 9034160 | |
| Pubmed | 2.28e-09 | 11 | 58 | 4 | 10720750 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 3.41e-09 | 12 | 58 | 4 | 7706460 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 4.40e-09 | 3 | 58 | 3 | 8363592 | |
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 9855620 | ||
| Pubmed | 4.40e-09 | 3 | 58 | 3 | 8912648 | ||
| Pubmed | 4.92e-09 | 13 | 58 | 4 | 10585447 | ||
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 4.92e-09 | 13 | 58 | 4 | 17425406 | |
| Pubmed | 9.37e-09 | 15 | 58 | 4 | 1741163 | ||
| Pubmed | 1.76e-08 | 4 | 58 | 3 | 32152050 | ||
| Pubmed | 2.09e-08 | 18 | 58 | 4 | 20056724 | ||
| Pubmed | 2.39e-08 | 183 | 58 | 7 | 23956138 | ||
| Pubmed | 4.08e-08 | 21 | 58 | 4 | 32301970 | ||
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 5.24e-07 | 10 | 58 | 3 | 11535246 | |
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 2.73e-06 | 2 | 58 | 2 | 14871892 | |
| Pubmed | Single nucleotide polymorphisms in SULT1A1 and SULT1A2 in a Korean population. | 2.73e-06 | 2 | 58 | 2 | 23358261 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 2.73e-06 | 2 | 58 | 2 | 38069221 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 11207031 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12761191 | ||
| Pubmed | Genetic polymorphisms of sulfotransferases (SULT1A1 and SULT1A2) in a Turkish population. | 2.73e-06 | 2 | 58 | 2 | 20936502 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 10543947 | ||
| Pubmed | Primary structures and properties of two related forms of aryl sulfotransferases in human liver. | 2.73e-06 | 2 | 58 | 2 | 7581483 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 29705271 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 15752422 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 20417180 | ||
| Pubmed | Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2. | 2.73e-06 | 2 | 58 | 2 | 10762004 | |
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 2.73e-06 | 2 | 58 | 2 | 8117269 | |
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 9566757 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8093002 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 12469224 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 31145702 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 10617600 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 16133548 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 8033246 | ||
| Pubmed | 2.73e-06 | 2 | 58 | 2 | 26549638 | ||
| Pubmed | Maps from two interspecific backcross DNA panels available as a community genetic mapping resource. | 6.58e-06 | 72 | 58 | 4 | 8075499 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 7695643 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 35679685 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 8.19e-06 | 3 | 58 | 2 | 26067475 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 18259693 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26206180 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26780727 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 7961757 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 8.19e-06 | 3 | 58 | 2 | 24039991 | |
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 27315375 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 26455829 | ||
| Pubmed | 8.19e-06 | 3 | 58 | 2 | 33128390 | ||
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 8661000 | ||
| Pubmed | A zonal organization of odorant receptor gene expression in the olfactory epithelium. | 1.64e-05 | 4 | 58 | 2 | 7683976 | |
| Pubmed | miR-221 regulates CD44 in hepatocellular carcinoma through the PI3K-AKT-mTOR pathway. | 1.64e-05 | 4 | 58 | 2 | 28442344 | |
| Pubmed | 1.64e-05 | 4 | 58 | 2 | 29203244 | ||
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 26169578 | ||
| Pubmed | Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition. | 2.72e-05 | 5 | 58 | 2 | 27048245 | |
| Pubmed | mTOR associates with TFIIIC, is found at tRNA and 5S rRNA genes, and targets their repressor Maf1. | 2.72e-05 | 5 | 58 | 2 | 20543138 | |
| Pubmed | 2.72e-05 | 5 | 58 | 2 | 11111040 | ||
| Pubmed | 4.08e-05 | 6 | 58 | 2 | 21840941 | ||
| Pubmed | Human SULT1A3 pharmacogenetics: gene duplication and functional genomic studies. | 4.08e-05 | 6 | 58 | 2 | 15358107 | |
| Pubmed | 5.71e-05 | 7 | 58 | 2 | 24136195 | ||
| Pubmed | Saturation mutagenesis defines novel mouse models of severe spine deformity. | 7.60e-05 | 8 | 58 | 2 | 34142127 | |
| Pubmed | 7.60e-05 | 8 | 58 | 2 | 20070850 | ||
| Pubmed | 1.04e-04 | 653 | 58 | 7 | 22586326 | ||
| Pubmed | 1.22e-04 | 10 | 58 | 2 | 27618784 | ||
| Pubmed | 1.22e-04 | 1440 | 58 | 10 | 30833792 | ||
| Pubmed | Functional analysis of Asb-1 using genetic modification in mice. | 1.49e-04 | 11 | 58 | 2 | 11509662 | |
| Pubmed | 1.49e-04 | 11 | 58 | 2 | 25104021 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.63e-04 | 942 | 58 | 8 | 31073040 | |
| Pubmed | Common variants at five new loci associated with early-onset inflammatory bowel disease. | 1.78e-04 | 12 | 58 | 2 | 19915574 | |
| Pubmed | Evolution of odorant receptors expressed in mammalian testes. | 2.11e-04 | 13 | 58 | 2 | 11014824 | |
| Pubmed | 2.46e-04 | 14 | 58 | 2 | 7528109 | ||
| Pubmed | Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. | 2.46e-04 | 14 | 58 | 2 | 18988856 | |
| Pubmed | Enoyl-CoA hydratase-1 regulates mTOR signaling and apoptosis by sensing nutrients. | 2.46e-04 | 14 | 58 | 2 | 28878358 | |
| Pubmed | Bladder cancer risk and genetic variation in AKR1C3 and other metabolizing genes. | 2.83e-04 | 15 | 58 | 2 | 18632753 | |
| Pubmed | Transcription Factor hDREF Is a Novel SUMO E3 Ligase of Mi2α. | 3.23e-04 | 16 | 58 | 2 | 27068747 | |
| Pubmed | 3.23e-04 | 16 | 58 | 2 | 12419832 | ||
| Pubmed | 3.38e-04 | 560 | 58 | 6 | 35241646 | ||
| Interaction | SULT1C2 interactions | 2.16e-07 | 19 | 57 | 4 | int:SULT1C2 | |
| Interaction | SULT1A3 interactions | 5.86e-07 | 24 | 57 | 4 | int:SULT1A3 | |
| Interaction | GPR17 interactions | 1.25e-06 | 283 | 57 | 8 | int:GPR17 | |
| Interaction | SULT1A4 interactions | 7.64e-06 | 14 | 57 | 3 | int:SULT1A4 | |
| Interaction | SULT1A2 interactions | 2.01e-05 | 19 | 57 | 3 | int:SULT1A2 | |
| Interaction | SULT2B1 interactions | 2.66e-05 | 61 | 57 | 4 | int:SULT2B1 | |
| Interaction | TACSTD2 interactions | 3.19e-05 | 129 | 57 | 5 | int:TACSTD2 | |
| Interaction | SULT1A1 interactions | 3.86e-05 | 67 | 57 | 4 | int:SULT1A1 | |
| Interaction | SULT4A1 interactions | 4.16e-05 | 24 | 57 | 3 | int:SULT4A1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p11 | 2.77e-05 | 278 | 58 | 5 | chr16p11 | |
| Cytoband | 16p12.1 | 4.62e-04 | 25 | 58 | 2 | 16p12.1 | |
| Cytoband | 7q33 | 1.25e-03 | 41 | 58 | 2 | 7q33 | |
| GeneFamily | Sulfotransferases, cytosolic | 2.02e-08 | 14 | 40 | 4 | 762 | |
| GeneFamily | Armadillo repeat containing|Importins | 7.14e-04 | 18 | 40 | 2 | 596 | |
| GeneFamily | Ankyrin repeat domain containing | 1.96e-03 | 242 | 40 | 4 | 403 | |
| Coexpression | VERNOCHET_ADIPOGENESIS | 2.07e-07 | 24 | 57 | 4 | MM1317 | |
| Coexpression | LANDIS_BREAST_CANCER_PROGRESSION_DN | 6.25e-07 | 75 | 57 | 5 | MM1084 | |
| Coexpression | BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_DN | 1.48e-05 | 68 | 57 | 4 | MM770 | |
| Coexpression | LANDIS_ERBB2_BREAST_TUMORS_324_DN | 2.36e-05 | 157 | 57 | 5 | MM1099 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_7 | 3.41e-05 | 84 | 57 | 4 | MM873 | |
| Coexpression | SOBOLEV_PBMC_PANDEMRIX_AGE_18_64YO_MEDIUM_HIGH_ADVERSE_EVENTS_SCORE_1DY_DN | 4.63e-05 | 5 | 57 | 2 | M41007 | |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_DP_THYMOCYTES_DN | 6.31e-05 | 193 | 57 | 5 | M7544 | |
| Coexpression | GSE339_CD8POS_VS_CD4CD8DN_DC_IN_CULTURE_DN | 7.46e-05 | 200 | 57 | 5 | M5128 | |
| Coexpression | LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP | 9.10e-05 | 108 | 57 | 4 | MM1334 | |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_LARGE_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_DN | 9.13e-05 | 491 | 57 | 7 | MM455 | |
| Coexpression | LE_EGR2_TARGETS_DN | 1.24e-04 | 117 | 57 | 4 | MM1139 | |
| Drug | barium hydroxide | 1.47e-10 | 31 | 58 | 6 | CID000028387 | |
| Drug | pedunculagin | 1.02e-09 | 19 | 58 | 5 | CID000442688 | |
| Drug | dopamine-4-O-sulfate | 1.32e-09 | 7 | 58 | 4 | CID000123932 | |
| Drug | 2-naphthylsulfate | 1.32e-09 | 7 | 58 | 4 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 1.32e-09 | 7 | 58 | 4 | CID003035977 | |
| Drug | luciferyl sulfate | 1.32e-09 | 7 | 58 | 4 | CID011953812 | |
| Drug | 2-iodophenol | 2.63e-09 | 8 | 58 | 4 | CID000010784 | |
| Drug | dopamine 3-O-sulfate | 2.63e-09 | 8 | 58 | 4 | CID000122136 | |
| Drug | 6-anilino-2-thiouracil | 2.63e-09 | 8 | 58 | 4 | CID003037707 | |
| Drug | AalphaC | 3.68e-09 | 24 | 58 | 5 | CID000062805 | |
| Drug | glycolithocholic acid | 5.68e-09 | 26 | 58 | 5 | CID000115245 | |
| Drug | EM-139 | 2.66e-08 | 13 | 58 | 4 | CID000131427 | |
| Drug | naphthalenemethanol | 3.72e-08 | 14 | 58 | 4 | CID000020908 | |
| Drug | deoxoestrone | 3.72e-08 | 14 | 58 | 4 | CID000005888 | |
| Drug | arylsulfate | 5.07e-08 | 15 | 58 | 4 | CID000074426 | |
| Drug | cyclobenzaprine | 5.07e-08 | 15 | 58 | 4 | CID000002895 | |
| Drug | A-44 | 6.74e-08 | 16 | 58 | 4 | CID000120353 | |
| Drug | benzilic acid | 8.80e-08 | 17 | 58 | 4 | CID000006463 | |
| Drug | AC1Q6OHG | 1.43e-07 | 19 | 58 | 4 | CID000115063 | |
| Drug | PLP-Glu | 1.78e-07 | 20 | 58 | 4 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 2.20e-07 | 21 | 58 | 4 | CID000005895 | |
| Drug | MeA alpha C | 2.68e-07 | 22 | 58 | 4 | CID000062244 | |
| Drug | AABSSN | 2.68e-07 | 22 | 58 | 4 | CID005464134 | |
| Drug | MeIQx | 2.84e-07 | 55 | 58 | 5 | CID000062275 | |
| Drug | taselin | 3.24e-07 | 23 | 58 | 4 | CID000023846 | |
| Drug | AzMC | 4.61e-07 | 25 | 58 | 4 | CID000064986 | |
| Drug | minoxidil sulphate | 4.61e-07 | 25 | 58 | 4 | CID000004202 | |
| Drug | 2-pentanone | 4.61e-07 | 25 | 58 | 4 | CID000007895 | |
| Drug | alpha-methyldopamine | 5.43e-07 | 26 | 58 | 4 | CID000017005 | |
| Drug | 1m2q | 5.43e-07 | 26 | 58 | 4 | CID005326637 | |
| Drug | Phosphoadenosine Phosphosulfate | 5.45e-07 | 7 | 58 | 3 | ctd:D010724 | |
| Drug | epicatechin-3-gallate | 6.61e-07 | 65 | 58 | 5 | CID000065056 | |
| Drug | Glu-P-2 | 8.58e-07 | 29 | 58 | 4 | CID000049970 | |
| Drug | N-hydroxy-4-aminobiphenyl | 8.71e-07 | 8 | 58 | 3 | ctd:C014593 | |
| Drug | 3,3'-T2 | 9.89e-07 | 30 | 58 | 4 | CID000065559 | |
| Drug | A2'p5'A2'p5'A | 1.13e-06 | 31 | 58 | 4 | CID000122642 | |
| Drug | acetaminophen sulfate | 1.13e-06 | 31 | 58 | 4 | CID000083939 | |
| Drug | DCNP | 1.47e-06 | 33 | 58 | 4 | CID000012066 | |
| Drug | mefenamic acid | 2.35e-06 | 37 | 58 | 4 | CID000004044 | |
| Drug | phenylhydroxylamine | 2.62e-06 | 38 | 58 | 4 | CID000007518 | |
| Drug | d-equilenin | 3.58e-06 | 41 | 58 | 4 | CID000010597 | |
| Drug | 2-naphthol | 3.94e-06 | 93 | 58 | 5 | CID000008663 | |
| Drug | L-alpha-methyldopa | 3.95e-06 | 42 | 58 | 4 | CID000004138 | |
| Drug | Woodward's reagent K | 4.34e-06 | 43 | 58 | 4 | CID000077804 | |
| Drug | NSC674039 | 4.77e-06 | 44 | 58 | 4 | CID000001249 | |
| Drug | adenosine 3'-5'-diphosphate | 5.10e-06 | 98 | 58 | 5 | CID000000073 | |
| Drug | 1IIg | 5.22e-06 | 45 | 58 | 4 | CID000001682 | |
| Drug | NDPS | 5.22e-06 | 45 | 58 | 4 | CID000090363 | |
| Drug | 4-octylphenol | 6.23e-06 | 47 | 58 | 4 | CID000015730 | |
| Drug | 5-hydroxymethylfurfural | 6.38e-06 | 2 | 58 | 2 | ctd:C008046 | |
| Drug | Hydroxytryptophol | 6.38e-06 | 2 | 58 | 2 | ctd:D006917 | |
| Drug | 6-hydroxymelatonin | 6.38e-06 | 2 | 58 | 2 | ctd:C012365 | |
| Drug | salicylamide | 6.78e-06 | 48 | 58 | 4 | CID000005147 | |
| Drug | sulfamethazine | 6.78e-06 | 48 | 58 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 6.78e-06 | 48 | 58 | 4 | CID000005896 | |
| Drug | A21250 | 7.15e-06 | 105 | 58 | 5 | CID000000990 | |
| Drug | VAL-TYR | 8.58e-06 | 16 | 58 | 3 | CID004065033 | |
| Drug | 9-hydroxybenzo(a)pyrene | 1.01e-05 | 53 | 58 | 4 | CID000028598 | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.05e-05 | 196 | 58 | 6 | 5523_DN | |
| Drug | androstenediol | 1.09e-05 | 54 | 58 | 4 | CID000010634 | |
| Drug | minoxidil | 1.09e-05 | 54 | 58 | 4 | CID000004201 | |
| Drug | gallic acid | 1.16e-05 | 116 | 58 | 5 | CID000000370 | |
| Drug | pentachlorophenol | 1.37e-05 | 120 | 58 | 5 | CID000000992 | |
| Drug | phenylglyoxal | 1.43e-05 | 121 | 58 | 5 | CID000014090 | |
| Drug | NSC36919 | 1.45e-05 | 58 | 58 | 4 | CID000235496 | |
| Drug | PhIP-HCl | 1.55e-05 | 123 | 58 | 5 | CID000001530 | |
| Drug | 4-hydroxyestrone | 1.55e-05 | 59 | 58 | 4 | CID000018418 | |
| Drug | acetaminophen glucuronide | 1.55e-05 | 59 | 58 | 4 | CID000083944 | |
| Drug | 5-hydroxy-3-methylindole | 1.91e-05 | 3 | 58 | 2 | CID000192734 | |
| Drug | 5-hydroxyindole | 1.91e-05 | 3 | 58 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 1.91e-05 | 3 | 58 | 2 | ctd:D008914 | |
| Drug | 8-azaadenine | 1.91e-05 | 3 | 58 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 1.91e-05 | 3 | 58 | 2 | ctd:C030629 | |
| Drug | 3-OHBaP | 2.02e-05 | 63 | 58 | 4 | CID000025890 | |
| Drug | 4-nonylphenol | 2.15e-05 | 64 | 58 | 4 | CID000001752 | |
| Drug | Pyrethroids | 3.24e-05 | 71 | 58 | 4 | CID000005053 | |
| Drug | adenylylsulfate | 3.43e-05 | 72 | 58 | 4 | CID000000228 | |
| Drug | 2'-phosphoadenosine 5'-phosphate | 3.62e-05 | 73 | 58 | 4 | CID000002027 | |
| Drug | Chebi:32701 | 3.81e-05 | 4 | 58 | 2 | CID005460855 | |
| Drug | 7-hydroxycoumarin | 4.03e-05 | 75 | 58 | 4 | CID005281426 | |
| Drug | benzyloxyresorufin | 4.70e-05 | 78 | 58 | 4 | CID000114982 | |
| Drug | catechol | 4.83e-05 | 257 | 58 | 6 | CID000000289 | |
| Drug | 4-hydroxyestradiol | 4.94e-05 | 79 | 58 | 4 | CID000001743 | |
| Drug | reverse T3 | 5.72e-05 | 82 | 58 | 4 | CID000022069 | |
| Drug | harmol | 6.35e-05 | 5 | 58 | 2 | ctd:C001326 | |
| Drug | pinocembrin | 6.35e-05 | 5 | 58 | 2 | ctd:C016063 | |
| Drug | TKPP | 6.35e-05 | 5 | 58 | 2 | CID000023740 | |
| Drug | 4-aminobiphenyl | 8.96e-05 | 92 | 58 | 4 | CID000007102 | |
| Drug | p-nitroanisole | 8.96e-05 | 92 | 58 | 4 | CID000007485 | |
| Drug | 2-Sulfotrehalose | 9.50e-05 | 6 | 58 | 2 | CID000124677 | |
| Drug | N-hydroxy-2-acetylaminophenanthrene | 9.50e-05 | 6 | 58 | 2 | CID000017102 | |
| Drug | Caffeic Acid-13C3 | 1.02e-04 | 95 | 58 | 4 | CID000002518 | |
| Drug | 1-naphthol | 1.15e-04 | 98 | 58 | 4 | CID000007005 | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.20e-04 | 189 | 58 | 5 | 1643_DN | |
| Drug | Mitoxantrone dihydrochloride [70476-82-3]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 1.23e-04 | 190 | 58 | 5 | 3232_UP | |
| Drug | 1 C2 | 1.24e-04 | 100 | 58 | 4 | CID005327152 | |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.32e-04 | 193 | 58 | 5 | 6215_DN | |
| Drug | AC1L577W | 1.33e-04 | 7 | 58 | 2 | CID000171279 | |
| Drug | N-acetyl-2-naphthylhydroxylamine | 1.33e-04 | 7 | 58 | 2 | CID000017272 | |
| Drug | Sparteine (-) [90-39-1]; Down 200; 17uM; MCF7; HT_HG-U133A | 1.36e-04 | 194 | 58 | 5 | 4391_DN | |
| Disease | X-12707 measurement | 2.14e-04 | 12 | 54 | 2 | EFO_0800720 | |
| Disease | ascorbic acid 3-sulfate measurement | 2.95e-04 | 14 | 54 | 2 | EFO_0800173 | |
| Disease | Autosome Abnormalities | 3.88e-04 | 16 | 54 | 2 | C0004403 | |
| Disease | Chromosome Aberrations | 3.88e-04 | 16 | 54 | 2 | C0008625 | |
| Disease | body mass index, type 2 diabetes mellitus | 3.88e-04 | 16 | 54 | 2 | EFO_0004340, MONDO_0005148 | |
| Disease | prostate cancer (is_implicated_in) | 1.30e-03 | 117 | 54 | 3 | DOID:10283 (is_implicated_in) | |
| Disease | Ovarian Mucinous Adenocarcinoma | 1.48e-03 | 31 | 54 | 2 | C1335167 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LPLFDAIRPLIPLKH | 56 | Q9Y6N9 | |
| AARLPLKLPTLHPKA | 46 | A0A1B0GUX0 | |
| LLKSPAPPLLHVAAL | 121 | Q8N163 | |
| HRAIPLLSLPLSLKK | 401 | Q9Y574 | |
| LGKHRLHLIPSLPLP | 311 | Q9Y576 | |
| LHLIPSLPLPDPIKK | 316 | Q9Y576 | |
| SPHFLLVVLLKLPLL | 171 | Q496F6 | |
| KPTLPLRLLHPSPDL | 366 | Q8IY22 | |
| ALVLPDLLHAKLPPD | 571 | P52824 | |
| LRLLLAALTRPAPHP | 681 | Q96C12 | |
| ARVLEPLLLLLLHPK | 991 | Q5JWR5 | |
| PLLLLLLHPKTQRVS | 996 | Q5JWR5 | |
| SPLLLPVLLLHPQEK | 2801 | Q96M86 | |
| PLKIHPLVRLPLATI | 506 | O94776 | |
| LLLLLAPPARAPKPS | 11 | Q9NPA2 | |
| PPLSLLLEHLPKLQP | 436 | Q9UBK8 | |
| PLLALLHAAPRPLLL | 576 | Q8NFR9 | |
| PPAPARRHLLVLLLL | 6 | Q9UK85 | |
| PHAPKLIPALLESLS | 1291 | Q5VYK3 | |
| PALLPLDLLLKVPPH | 956 | Q6ZWH5 | |
| LIHLVLLLPLPFCRP | 156 | Q96R45 | |
| LIHLVLLLPLPFCRP | 156 | O95047 | |
| LPLLLLAAPAPHRAS | 21 | Q9UMR5 | |
| PPSHSLLRLPLLQLL | 6 | Q96AY3 | |
| GEHPELRKSLLPPLI | 1026 | O43497 | |
| PPHVLREKCLLPLQL | 41 | Q5TH69 | |
| PKLTDLENLHLPLPL | 131 | P05814 | |
| IPLVPLRKLLLHGPC | 221 | Q8N2R8 | |
| MPLLLLLLLLPSPLH | 1 | P07359 | |
| HLALRPICSLPPLLT | 321 | A6NKP2 | |
| LLLLPLPVLHPSSEA | 21 | Q9UKG4 | |
| ALLKNRLLPPLLHTL | 281 | Q8TEX9 | |
| RLLPPLLHTLFPIVA | 286 | Q8TEX9 | |
| PALLPHEAPELLLLL | 111 | O95992 | |
| MTPHRLLPPLLLLLA | 1 | P24592 | |
| AAIPLPRLKLLLNHT | 171 | Q6NXP6 | |
| LHLLLPPIVKLFDAP | 1111 | P42345 | |
| LLRVHKAPPVLPLLG | 66 | O15296 | |
| LLKSAPLLLPGRHLL | 766 | Q13423 | |
| KLPHKLPPLREPILL | 1781 | Q5TCS8 | |
| KRELSHPPLYRLPLL | 1311 | Q07890 | |
| LLLLFRSLKQHPPLL | 181 | O75192 | |
| SPLLPVSLLGPKHEL | 106 | O75925 | |
| LPLPLPPKKTRIISH | 311 | P42338 | |
| APPLLHLDLKPANIL | 136 | P57078 | |
| LPPHTLSPVLVKLLA | 1031 | O60287 | |
| PPRLIKSHLPLALLP | 101 | P0DMN0 | |
| PPRLIKSHLPLALLP | 101 | P0DMM9 | |
| HRLTLPLPKSGLLLK | 586 | Q96JN2 | |
| LPPLPAKRHLAELSV | 141 | Q96P48 | |
| KLSHPLLEQLLPALR | 451 | Q86XI2 | |
| SLLTQLELHPPLLPL | 531 | Q96LI5 | |
| FLLVRKLPPLCHGLP | 36 | Q9Y320 | |
| LLLRHPLHLPIPQSL | 451 | Q6ZTK2 | |
| MGHPPLLPLLLLLHT | 1 | Q03405 | |
| GVPHSKRLLPLLSLI | 251 | Q96AG3 | |
| APRLLKTHLPLALLP | 101 | P50225 | |
| APRLLKTHLPLALLP | 101 | P50226 | |
| LLPHLLPLLKGLLFH | 391 | O14787 | |
| VPPLLLPHFRAALAL | 646 | Q9BRR9 | |
| TPRKAPLLPRLGLLA | 486 | Q8WUA4 | |
| GPLLTPALLPHRILS | 361 | Q9HBM0 | |
| LVPLPEALLLHLPAL | 291 | Q8WUA8 | |
| ARAPLPLALLLSLPA | 6 | Q6UXQ8 |